Pre-transplant Rehabilitation to Decrease the Post-transplant Length of Stay for Hematological Malignancy Patients Undergoing Allo-HSCT.
allogeneic hematopoietic stem cell transplantation
hematological malignancy
length of stay
pre-transplant rehabilitation
Journal
Progress in rehabilitation medicine
ISSN: 2432-1354
Titre abrégé: Prog Rehabil Med
Pays: Japan
ID NLM: 101707740
Informations de publication
Date de publication:
2021
2021
Historique:
received:
05
11
2020
accepted:
07
04
2021
entrez:
3
5
2021
pubmed:
4
5
2021
medline:
4
5
2021
Statut:
epublish
Résumé
Pre-transplant rehabilitation for hematological malignancy patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) helps improve physical capacity. However, its benefit with respect to post-transplant hospital length of stay (LOS) is unclear. Consequently, the aim of this study was to investigate the effect of pre-transplant rehabilitation on post-transplant LOS for hematological malignancy patients undergoing allo-HSCT. Data on patients diagnosed between April 2014 and March 2017 were collected from the Japanese Diagnosis Procedure Combination database. The patients were identified using the ICD-10 codes C81-85, C90-94, C96, and D46. Multilevel linear regression analyses were conducted to identify the effects of pre-transplant rehabilitation on post-transplant LOS (log transformed). In total, 3614 patients were included in the study. Pre-transplant rehabilitation was associated with a significant reduction in post-transplant hospital LOS (β=-0.134, P<0.001). Pre-transplant rehabilitation may be an effective strategy for shortening the post-transplant hospital LOS in hematological malignancy patients undergoing allo-HSCT. Consequently, it may be necessary to consider starting rehabilitation before transplantation.
Identifiants
pubmed: 33937548
doi: 10.2490/prm.20210020
pii: 20210020
pmc: PMC8080154
doi:
Types de publication
Journal Article
Langues
eng
Pagination
20210020Informations de copyright
©2021 The Japanese Association of Rehabilitation Medicine.
Déclaration de conflit d'intérêts
CONFLICTS OF INTEREST: The authors declare that there are no conflicts of interest.
Références
Bone Marrow Transplant. 2005 Jun;35(11):1113-6
pubmed: 15821765
J Orthop Sci. 2020 Jan;25(1):127-131
pubmed: 30799165
Support Care Cancer. 2015 Apr;23(4):985-92
pubmed: 25256376
Curr Med Res Opin. 2019 Dec;35(12):2089-2096
pubmed: 31353971
Support Care Cancer. 2020 Jul;28(7):3189-3196
pubmed: 31712955
Bone Marrow Transplant. 2010 Feb;45(2):355-62
pubmed: 19597418
J Formos Med Assoc. 2021 Jan 8;:
pubmed: 33423899
Lung Cancer. 2011 Dec;74(3):441-5
pubmed: 21663994
Ann Thorac Cardiovasc Surg. 2011;17(5):461-8
pubmed: 21881371
Bone Marrow Transplant. 2008 Jun;41(11):965-9
pubmed: 18264142
Interact Cardiovasc Thorac Surg. 2016 Sep;23(3):486-97
pubmed: 27226400
Blood. 2011 Mar 3;117(9):2604-13
pubmed: 21190995
Phys Ther. 2013 Apr;93(4):514-28
pubmed: 23224217
Cancer Treat Rev. 2013 Oct;39(6):682-90
pubmed: 23485478
Biol Blood Marrow Transplant. 2017 Apr;23(4):659-669
pubmed: 28042020
Arch Phys Med Rehabil. 2013 Jan;94(1):53-8
pubmed: 22926460
Jpn J Clin Oncol. 2018 Dec 1;48(12):1046-1057
pubmed: 30277514
Chest. 2005 Jul;128(1):145-52
pubmed: 16002928
Curr Med Res Opin. 2019 Jun;35(6):983-988
pubmed: 30461314
Support Care Cancer. 2007 May;15(5):491-6
pubmed: 17139495
Support Care Cancer. 2020 Dec;28(12):5851-5860
pubmed: 32253603
Support Care Cancer. 2012 Apr;20(4):821-9
pubmed: 21479522
Ann Clin Microbiol Antimicrob. 2020 Feb 17;19(1):7
pubmed: 32066448
Bone Marrow Transplant. 2009 May;43(9):725-37
pubmed: 19234513
Bone Marrow Transplant. 2008 Feb;41(4):321-9
pubmed: 18026154
Physiother Theory Pract. 2018 Oct;34(10):747-756
pubmed: 29336645
Cochrane Database Syst Rev. 2017 Jun 07;6:CD012020
pubmed: 28589547
Bone Marrow Transplant. 2013 Oct;48(10):1342-9
pubmed: 23584437
J Clin Oncol. 2002 Apr 1;20(7):1907-17
pubmed: 11919251
Support Care Cancer. 2018 Jul;26(7):2149-2160
pubmed: 29372395
Annu Rev Public Health. 2000;21:171-92
pubmed: 10884951
J Surg Res. 2017 Mar;209:30-36
pubmed: 28032568